These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 74877)

  • 1. Specific blocking of MLR-stimulating determinants (HLA-D) with B-cell alloantisera: preabsorption of antibody on stimulator cells.
    Hansen JA; Lee TD; Whitsett CF; Dupont B
    Transplant Proc; 1977 Dec; 9(4):1721-6. PubMed ID: 74877
    [No Abstract]   [Full Text] [Related]  

  • 2. A suppressor T cell of the mixed lymphocyte reaction specific for the HLA-D region in man.
    Engleman EG; McDevitt HO
    J Clin Invest; 1978 Mar; 61(3):828-38. PubMed ID: 147885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional properties of anti-B-cell antigen alloantisera.
    Ferrone S; Pellegrino MA; van Rood JJ; van Leeuwen A
    Transplant Proc; 1977 Mar; 9(1):675-8. PubMed ID: 141136
    [No Abstract]   [Full Text] [Related]  

  • 5. A human-human hybridoma secreting anti-HLA class II antibody.
    Effros RB; Hulette CM; Ettenger R; Dillard LC; Zeller E; Duong R; Walford RL
    J Immunol; 1986 Sep; 137(5):1599-603. PubMed ID: 2943797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Close genetic relationships between determinants of the HLA-D region detected by MLR-I, MLR-II, and B-lymphocyte serology.
    Sasportes M; Fradelizi D; Nunez-Roldan A; Dausset J
    Transplant Proc; 1978 Mar; 10(1):57-62. PubMed ID: 76352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inhibition of T-cell-mediated cytolosis by alloantiserum against HLA-D-related (DR) antigens.
    Feighery CF; Stastny P
    Transplant Proc; 1979 Mar; 11(1):708-11. PubMed ID: 88098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serologic identification of the common and idiotype-specific receptors on responder T cells for lymphocyte-activating determinants in mixed lymphocyte cultures.
    Sell KW; Ahmed A; Leapman SB; Strong DM
    Transplant Proc; 1977 Dec; 9(4):1737-43. PubMed ID: 74879
    [No Abstract]   [Full Text] [Related]  

  • 9. Mouse T lymphocytes proliferative responses specific for human MHC products in mouse anti-human xenogeneic MLR.
    Yoshizawa K; Yano A
    J Immunol; 1984 Jun; 132(6):2820-9. PubMed ID: 6202762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Ia-like DRw lymphocyte antigens stimulating activity in primary mixed lymphocyte reaction.
    Fradelizi D; Nunez-Roldan A; Sasportes M
    Eur J Immunol; 1978 Feb; 8(2):88-93. PubMed ID: 77783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capacity of B cells to function as stimulators of a primary mixed leukocyte reaction.
    Krieger JI; Chesnut RW; Grey HM
    J Immunol; 1986 Nov; 137(10):3117-23. PubMed ID: 2945857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T-cell hybrids with HLA-restricted proliferative response to Epstein-Barr virus-infected B cells.
    Gallagher G; Stimson WH
    Immunology; 1984 Dec; 53(4):611-21. PubMed ID: 6209205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human suppressor cell induction in vitro: preferential activation by class I MHC antigen.
    Goeken NE
    J Immunol; 1984 May; 132(5):2291-9. PubMed ID: 6232315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulatory determinants expressed on B cells which produce specific PLT reactivity.
    Reinsmoen NL; Noreen HJ; Greenberg LJ; Kersey JH
    Transplant Proc; 1978 Dec; 10(4):767-9. PubMed ID: 83709
    [No Abstract]   [Full Text] [Related]  

  • 17. Specific inhibition of human lymphocyte responses by primed autologous lymphocytes. I. Evaluation of MLR inhibition as a model for suppression.
    Sheehy MJ; Mawas C; Charmot D
    J Immunol; 1979 Jun; 122(6):2198-203. PubMed ID: 87456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B lymphocyte determinants in immunoglobulin A nephropathy.
    Friend PS; Yunis EJ; Noreen HJ; Reinsmoen N; Dubey D; Michael AF
    J Immunol; 1979 Nov; 123(5):2182-4. PubMed ID: 90705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy outcome in human couples with recurrent spontaneous abortions: HLA antigen profiles; HLA antigen sharing; female serum MLR blocking factors; and paternal leukocyte immunization.
    Beer AE; Semprini AE; Zhu XY; Quebbeman JF
    Exp Clin Immunogenet; 1985; 2(3):137-53. PubMed ID: 2978830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMLR and MLR stimulating activity of human T lymphocytes activated in vitro by soluble HLA-DR antigens.
    Vanoli M; Scorza Smeraldi R; Fabio G; Bonara P; Sabbadini MG; Zanussi C
    Clin Exp Immunol; 1986 Jan; 63(1):163-70. PubMed ID: 2420496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.